Launched in 2017, the JDRF-CIHR Partnership to Defeat Diabetes is a landmark collaboration between the Government of Canada, through the Canadian Institute of Health Research (CIHR) and JDRF Canada for […]
A significant part of JDRF’s research strategy is funding innovative therapies that can lead to treatment for type 1 diabetes (T1D) and eventually a cure. As part of this it […]
March 3, 2022 – Statement by Dave Prowten, President and CEO, JDRF Canada JDRF has long supported both public and private sector initiatives to make insulin more affordable to ensure […]
Grace Age: 16Lives in: West Vancouver, BC Grace’s hobbies include playing volleyball and maintaining an active lifestyle through health and fitness, as she loves spending time at the gym. She has been […]
The National Health Service (NHS) in England recently released two studies that provide the first information available about risks of COVID-19 in people with type 1 diabetes (T1D). The findings – which are still undergoing peer review – tell us that for people that need to be hospitalized due to COVID-19, those with type 1 diabetes are at higher risk of death than people with type 2 diabetes, or the general population.
Maybe you’ve never heard of the term ‘diabulimia’ before, but this eating disorder affecting people living with type 1 diabetes is more common than you might think.
Giving back to others has been a way of life since Tannis was a young girl growing up in Winnipeg. Her parents were always community-minded, with hersurgeon father establishing the first collective medical facility, the Winnipeg Clinic, and her mother lending support to various organizations.
To mark November’s National Diabetes Awareness Month, JDRF is excited to announce a new investment of $7 million to support four Canadian research teams as part of the JDRF-CIHR Partnership […]
Dr. Pepper is a promising young Canadian scientist and a new assistant professor in the Department of Surgery at the University of Alberta.
Dr. Suheda Erener is currently investigating whether micro-RNAs – a family of single-stranded molecules which are key regulators of gene expression and beta cell function – can predict the development of T1D.
Beta cells normally produce insulin, a chemical messenger that helps move sugar from food sources into cells throughout the body, which use it for fuel to stay alive.
Young people living with a chronic illness like type 1 diabetes (T1D) often experience anxiety which – if not treated – can quickly spiral downwards into depression. However, the link between diabetes and depression remains poorly understood and under-researched. Depression is often viewed as a natural outcome of “diabetes distress” – the emotional burden of living with the disease.
